Clinical trial
Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer
NCT00210171 · Institut Bergonié, Other · Withdrawn
Key facts
| NCT number | NCT00210171 |
|---|---|
| Title | Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer |
| Official title | Multicentric Phase II Study of Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer, With :- Induction Chemotherapy by Cisplatin - Docetaxel- Concomitant Chemo-radiotherapy by Weekly Cisplatin - Docetaxel- Consolidation Chemotherapy by Docetaxel |
| Acronym | BIB 01 |
| Lead sponsor | Institut Bergonié, Other |
| Collaborators | Sanofi Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Procedure |
| Interventions | Toxicity : Time to progression, 1 and 2 years survival |
| Enrollment | 0 |
| Start date | May 1, 2004 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 10, 2025 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: